
Reed Jobs would rather talk about curing cancer than his last name
THE SO WHAT
A 17-person Yosemite team leaning into oncology as blockbuster patents expire means more capital chasing post-patent white space—companion diagnostics, delivery tech, and next-gen therapies. If you operate in healthcare or biotech tooling, expect sharper diligence around real clinical leverage, not just AI-on-biology narratives.
READ THE SOURCE
MORE FROM THE WIRE
Startups & VentureGensler: Big Deals a Sign of 'High-Valuation Market'
When SK Hynix can raise $26.5B and Google can float an $85B deal, you’re operating in a high‑valuation regime where public markets are rewarding scale and story. For late‑stage companies, that’s a window to consider listing or secondary liquidity—while also tightening fundamentals in case multiples compress.
Startups & VentureHedge Fund Elliott Builds Stake in Software Firm CCC
Activist capital building a stake in a vertical software player exploring a sale is a reminder that underpriced, cash‑generating SaaS is now an M&A and activism target. If you run a similar asset, assume your valuation and strategic options are being modeled by funds—have a defensible plan or a sale narrative ready.
Startups & VentureMen’s Wearhouse Owner Tailored Brands Files Publicly for US IPO
Retail PE exits are back on the menu — a post-bankruptcy apparel rollup getting public-market appetite suggests investors are again willing to underwrite old-economy cash flows if the balance sheet is cleaned up. If you run a mature, cash-generative business that survived 2020–2023, IPO optionality just moved a notch higher.
Startups & VentureThe Week’s 10 Biggest Funding Rounds: A Pair Of Billion-Dollar Deals For Cyber And AI Infrastructure Lead
Billion‑dollar rounds into AI infra and cybersecurity say two things: investors expect AI workloads to keep compounding, and they expect the attack surface to grow just as fast. If you’re building in the AI stack, assume capital is available for infra and security moats—differentiation will come from integration into real workloads, not raw scale alone.